Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease ; volume:21 ; number:1 ; day:3 ; month:8 ; year:2021 ; pages:1-7 ; date:12.2021
BMC endocrine disorders ; 21, Heft 1 (3.8.2021), 1-7, 12.2021
- Creator
-
Yari, Fatemeh Ali
Shabani, Parisa
Karami, Sara
Sarmadi, Negar
Poustchi, Hossein
Bandegi, Ahmad Reza
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12902-021-00820-8
- URN
-
urn:nbn:de:101:1-2021103000363606069797
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yari, Fatemeh Ali
- Shabani, Parisa
- Karami, Sara
- Sarmadi, Negar
- Poustchi, Hossein
- Bandegi, Ahmad Reza
- SpringerLink (Online service)
Other Objects (12)
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr −/− mice
Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr −/− mice
Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr −/− mice